INmune Bio Competitors and Similar CompaniesClear all
INmune Bio's competitors and similar companies include CNS Pharmaceuticals, Takeda, PLIVA and Shanghai Junshi Biosciences.
 INmune Bio INmune Bio is a clinical-stage biotechnology company that develops immunotherapies that reprogram a patient’s innate immune system. |  CNS Pharmaceuticals CNS Pharmaceuticals is a pre-clinical stage biotechnology company specializing in the development of treatments for brain tumors. |  Takeda Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. |  PLIVA PLIVA HRVATSKA is a pharmaceutical company focused on the development of generic and niche products. |  Shanghai Junshi Biosciences Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases. | |
Founding Date | Founding Date 2015 | Founding Date 2017 | Founding Date 1781 | Founding Date 1921 | Founding Date 2012 |
Type | Type Public | Type Public | Type Public | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations Boca Raton, US HQ | Locations Houston, US HQ | Locations Zagreb, HR HQ Sarajevo, BA Skopje, MK Belgrade, RS | Locations Shanghai, CN HQ | |
Employees | Employees 22100% increase | Employees 433% increase | Employees 47,4554% decrease | Employees 1,685 | Employees 2,578 |
Valuation ($) | Valuation ($) 124.9 m | Valuation ($) 4.7 m | Valuation ($) 43.7 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $50k (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ¥4.6t (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ¥2.4b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥818.8b (FY, 2025) | Cost of goods N/A | Cost of goods ¥466.5m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit ¥3.8t (FY, 2025) | Gross profit N/A | Gross profit ¥2b (FY, 2025) |
Net income | Net income N/A | Net income ($15.9m) (FY, 2025) | Net income ¥108.1b (FY, 2025) | Net income N/A | Net income (¥1b) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 23.2m | Total funding raised N/A | Total funding raised $ 57.8m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
CNS Pharmaceuticals
HQ
Houston, US
Employees
4↑ 33% increase
CNS Pharmaceuticals is a pre-clinical stage biotechnology company specializing in the development of treatments for brain tumors.
View companyTakeda
HQ
Tokyo, JP
Employees
47,455↓ 4% decrease
Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
View companyPLIVA
HQ
Zagreb, HR
PLIVA HRVATSKA is a pharmaceutical company focused on the development of generic and niche products.
View companyShanghai Junshi Biosciences
HQ
Shanghai, CN
Employees
2,578
Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases.
View company